The substrate of matrix metalloproteinase 11 (MMP11) remains unknown. We have recently shown that MMP11 is a negative regulator of adipogenesis, able to reduce and even to revert mature adipocyte differentiation. Here, we have used mouse 3T3L1 cells and human U87MG and SaOS cells to show that MMP11 cleaves the native a3 chain of collagen VI, which is an adipocyte-related extracellular matrix component. It is known that extracellular proteolytic processing of this chain is required for correct collagen VI folding. Interestingly, MMP11-deficient fat tissue is less cohesive and exhibits collagen VI alteration, dramatic adipocyte plasma and basement membrane abnormalities and lipid leakage. MMP11 is thus required for correct collagen VI folding and therefore for fat tissue cohesion and adipocyte function. Both MMP11 and collagen VI favor tumor progression. Similar spatio-temporal overexpression at the adipocyte-cancer cell interface has been reported for the two proteins. MMP11-dependent collagen VI processing might therefore be expected to occur during malignancy. Accordingly, collagen VI no longer delineates adipocytes located at the invasive front of breast carcinomas. In conclusion, the native a3 chain of collagen VI constitutes a specific MMP11 substrate. This MMP11 collagenolytic activity is functional in fat tissue ontogenesis as well as during cancer invasive steps.
Introduction
Matrix metalloproteinase-11 (MMP11)/stromelysin-3 is a zinc endopeptidase belonging to the MMP family. This enzyme has been shown to be involved in tissue remodeling during embryogenesis, wound healing, tissue involution and metamorphosis (Rio, 2002) . More importantly, MMP11 is expressed by the peritumoral fibroblasts, and high levels of expression correlate with tumor aggressiveness as well as with poor patient clinical outcome (Basset et al., 1990; Basset et al., 1997) . In vivo studies using different mouse tumor models showed that MMP11 plays a key role in tumor development (Masson et al., 1998; Noel et al., 2000) and that it acts at the initial step of the invasive processes (Boulay et al., 2001) . At this step, the invasive cancer cells establish an epithelial/mesenchymal heterotypic cell interaction inducing dramatic remodeling of the adjacent connective tissue through desmoplasia, leading to the formation of the stroma. One of the major changes seen during desmoplasia is the accumulation of fibroblasts and the disappearance of adipocytes. Recently, the relevance of adipocytes and adipocyte-derived factors to cancer cell survival and growth has started to receive increasing attention (Manabe et al., 2003; Celis et al., 2005; Dieudonne et al., 2006; Schaffler et al., 2007) . We recently showed that MMP11 is a negative regulator of adipogenesis not only able to reduce preadipocyte differentiation but also to revert mature adipocytes into preadipocytes (Andarawewa et al., 2005) . This function is aberrantly restored in carcinomas. Thus, invasive cancer cells at the tumor invasive front induce proximal adipocytes to express MMP11 inducing therefore the dedifferentiation of peritumoral adipocytes into fibroblasts. Thus, at an early stage of tumor invasion, MMP11 helps the implantation of cancer cells into adjacent connective tissue via cancer cell-adipocyte interaction (reviewed in Motrescu and Rio, 2008) .
Despite extensive research from several laboratories using various approaches, the specific substrate of MMP11 has not yet been found. In this context, adipocytes might offer the answer to this question. One good candidate which could be a target of MMP11 is collagen VI that has been shown to be expressed and secreted abundantly by adipocytes, and to be involved in cancer cell-adipocyte heterotypic signaling (Iyengar et al., 2003; Iyengar et al., 2005) . Collagen VI has a complex structure containing three different chains, a1 (around 150 kDa), a2 (around 150 kDa) and a3 (around 250 kDa) that associate intracellularly in triple helical monomers, dimers and tetramers. Once secreted, the tetramers associate end-to-end into microfibrils (Aigner et al., 2002) . Collagen VI participates in the local extracellular matrix (ECM) environment by providing structural support for cells and enrichment of various molecules, and can itself assume important signaling effects (Ruhl et al., 1999) . Thus, it has been reported that adipocytes play a vital role in defining the ECM environment for normal and tumor-derived ductal epithelial cells and contribute significantly to tumor growth at early stages through secretion and processing of collagen VI (Iyengar et al., 2003; Iyengar et al., 2005) .
In the present study, we have investigated this hypothesis both in vitro and in vivo. We demonstrate that MMP11 indeed cleaves collagen VI. Only the native a3 chain of collagen VI is degraded by MMP11. Moreover, the absence of MMP11 in deficient mice dramatically alters the collagen VI folding and subsequently adipocytes and related ECM. Finally, the ectopic expression of MMP11 at the adipocyte-cancer cell interface leads to collagen VI alteration.
Results

MMP11 does not cleave purified pepsin-solubilized collagen VI
The capacity of MMP11 to cleave collagen VI was first investigated in test-tube experiments using recombinant MMP11 and commercially available purified human pepsin-solubilized collagen VI protein (Abcam, UK). The enzymatic efficiency of recombinant MMP11 protein was proved by using the a1 proteinase inhibitor (a1-PI) that has been shown to be degraded by MMP11 (Pei et al., 1994) . Silver nitrate staining showed that the a1-PI band disappeared in the presence of active MMP11 (Figure 1a ). Pepsin-solubilized collagen VI gave rise to three main bands at around 40, 50 and 60 kDa as shown by silver nitrate staining ( Figure 1b ) and by western blot using the rabbit anti-collagen VI polyclonal antibody LB-1697 (Gentaur, France; Figure 1c ). Addition of mouse active (lane 2) or inactive (lane 3) recombinant MMP11 did not affect the purified collagen VI protein (Figures 1b  and c) . MMP11 has thus no enzymatic function against pepsin-generated collagen VI fragments.
MMP11 acts on native collagen VI produced by DM-induced adipocyte-differentiated mouse 3T3L1 cells As there was no effect of MMP11 on pepsin-digested collagen VI, we were prompted to find some sources of native collagen VI to avoid the pepsination step that is involved in the purification of commercialized collagen VI. We therefore induced adipocyte differentiation in canonical mouse 3T3L1 fibroblasts that become preadipocytes when they reach confluence. Treatment of confluent cells with a differentiation-inducing mix (DM) induces the expression of proteins associated with mature adipocytes and the accumulation of lipids (Bernlohr et al., 1984) . Whereas the concentrated culture medium from confluent 3T3L1 fibroblasts expressed only a low level of collagen VI (Figure 2A upper part, lane 1), abundant collagen VI levels were shown at day 10 adipocyte-differentiated 3T3L1 (Figure 2A upper part, lane 2). We observed two main bands at around 250 and 150 kDa that presumably correspond to the a3 chain and to the a1 and a2 chains, respectively (Aigner et al., 2002) . The differentiation of the 3T3L1 fibroblasts ( Figure 2Ba ) into adipocytes ( Figure 2Bb ) was visualized by Oil Red O staining of lipid droplets. Moreover, using the 5ST-4A9 monoclonal antibody directed against MMP11, western blot analysis revealed only a very low level of endogenous MMP11 in confluent 3T3L1 fibroblasts, but not in adipocyte-differentiated 3T3L1 (Figure 2A , lower part, lanes 1 and 2, respectively). Thus, 3T3L1 differentiation into adipocyte is associated with an increase of collagen VI and a decrease of MMP11. These data suggested that MMP11 might have a function on native collagen VI.
MMP11 treatment of adipocyte-differentiated 3T3L1 leads to their dedifferentiation and to a decrease of collagen VI As no endogenous MMP11 was expressed in adipocytedifferentiated 3T3L1, we took advantage of this model to test the impact of MMP11 on native collagen VI. At day 10 after the start of differentiation, active or inactive forms of recombinant mouse MMP11 (3.5 mg/ml) were added over 72 h to the culture medium of adipocytedifferentiated 3T3L1. Subsequently, the cells were cultured for 24 h with the medium without fetal calf serum (FCS). The recombinant active MMP11 induces a (Figure 3Bb ), indicating that it induces the dedifferentiation of 3T3L1 adipocytes as already shown using a primary culture of mouse embryonic fibroblasts (Andarawewa et al., 2005) . The expression of collagen VI was checked in the concentrated culture media using western blot analysis ( Figure 3A) . A decrease in the collagen VI level was observed in the presence of active recombinant MMP11 ( Figure 3A , lane 2). Neither reduction of lipid droplets nor the collagen VI level was observed using the inactive recombinant MMP11 (Figures 3A and Bc, lane 3) , similar to the control (Figures 3A and Ba, lane 1) . These data strongly suggested that MMP11 cleaves the native collagen VI.
MMP11 cleaves the a3 chain of native collagen VI
To confirm this hypothesis, we performed test-tube digestion of native collagen VI produced by two human cell lines using recombinant MMP11. The human cells used were the glioblastoma U87MG cell line that has been shown to produce intact collagen VI including the a1 and a2 chains around 150 kDa each and the a3 chain around 250 kDa (Han and Daniel, 1995) , and the SaOS2 cell line that is deficient in production of a3 chain (Lamande et al., 2006) . Cell-conditioned culture media were collected and concentrated (see 'Materials and methods'). Western blot analysis showed two bands at around 150 and 250 kDa in U87MG and only one band at around 150 kDa for SaOS2 as was expected (Figure 4 , lane 1). The active and inactive forms of recombinant MMP11 were visualized using western blot and 5ST-4C10 monoclonal antibody ( Figure 4 , lanes 2 and 3, respectively). Note that autolysis is observed for the MMP11 active form (two bands) but not for the inactive one (one band). The concentrated cell-conditioned culture media were incubated with recombinant active or inactive MMP11 for 4.5 h at 37 1C at a ratio 5:1 w/w. In the presence of active MMP11, a degradation of the 250 kDa band was observed in U87MG. The 150 kDa band from the two cell lines however was unaffected ( Figure 4 , lane 2). No effect was observed in the case of incubation of culture media with inactive MMP11 (Figure 4 , lane 3). Thus, MMP11 does not affect the a1 and a2 chains of collagen VI, but specifically cleaves the a3 chain.
Mouse MMP11-deficient fat tissue shows collagen VI alteration To investigate the proteolytic function of MMP11 on collagen VI in vivo, we first compared the collagen VI present in adipose tissue of wild-type and MMP11-deficient mice previously developed in the laboratory (Masson et al., 1998) . Immunohistochemistry was performed on abdominal fat from 8-week-old wild-type or MMP11-deficient mice using the LB-1697 anti-collagen VI polyclonal antibody. Collagen VI was expressed in both animals, but the staining gave different images. In wild-type fat tissue, collagen VI staining appeared as a thin compact continuous band surrounding adipocytes (Figure 5a ). In MMP11-deficient mice, two types of collagen VI staining were observed. First, an enlarged and diffuse band surrounding adipocytes was seen (Figure 5b ), indicating a fault in collagen VI folding. Second, this staining was discontinuous and sometimes even totally lost at the cell-cell contact between two adjacent adipocytes, indicating that collagen VI fibrils were disrupted. Strong staining however remained present at the triangular interspaces existing between several adjacent adipocytes ( Figure 5c ). Finally, it might be expected that misfolded and unstable collagen VI could be unfunctional leading to ECM alteration. Accordingly, optical microscopic examination showed that adipose tissues were less cohesive in MMP11-deficient (Figures 5b and c) than in wild-type (Figure 5a ) mice. Overall these results show that the absence of MMP11 leads to alteration in fat tissue collagen VI folding and stability. Electron microscopy highlights numerous ultrastructural alteration of mouse MMP11-deficient adipocytes and related ECM We then performed electron microscopy to further visualize modifications occurring in the fat tissue of MMP11-deficient mice. The ultrastructural analysis showed that the ECM present at the interface between adipocytes was greatly altered. Whereas correctly folded continuous parallel collagen fibers were observed in wild-type mice (Figures 6a and b) , MMP11-deficient fat tissue showed disorganized and disrupted collagen structures (Figures 6c and d) . In addition, empty areas were observed. Moreover, alterations of adipocyte ultrastructure were also observed, which included disruption of adipocyte basement membrane, disruption and extension of adipocyte plasma membrane (Figures 6g and h ). Lipid leakage leading to lipid accumulation outside adipocytes and notably infiltration of lipid droplets into the cytoplasm of adjacent cells and in ECM were also present ( Figures  6f and g ). None of these modifications were observed in the fat tissue from wild-type mice (Figure 6e ). Incorrect collagen VI structure cause by the absence of MMP11 thus appears to lead to the alteration of both plasma and basement membranes of adipocytes and adipocyterelated ECM. For incubation the ratio 5:1 (w/w, concentrated culture medium to recombinant MMP11) was used. Recombinant active (lane 2) and inactive (lane 3) MMP11 proteins were visualized using the 5ST-4C10 monoclonal antibody. Note that two bands were observed for the MMP11 active form due to its autolysis. Active MMP11 treatment has no effect on the 150 kDa band of the two cell lines. The intensity of the staining of the 250 kDa band of U87MG is however dramatically decreased, indicating that it is cleaved by MMP11. Inactive MMP11 has no effect. The molecular sizes of endogenous collagen VI chains and recombinant MMP11 are indicated in kDa.
MMP11 participates in collagen VI alteration at the human tumor invasive front All the results collected above prompted us to investigate the possible involvement of this collagenolytic function of MMP11 in the invasive phase of tumor progression. Normal resting human adipocytes expressed collagen VI (Figure 7a ) but not MMP11 (Figure 7c) . However, as shown in our previous study (Andarawewa et al., 2005) , adipocytes located at the invasive front of human breast carcinoma are induced by invasive cancer cells to strongly express MMP11, and exhibit dramatically reduced sizes. It was therefore tempting to speculate that, at the tumor invasive front, the ectopically expressed and secreted MMP11 might alter collagen VI normally present around adipocytes. We therefore checked the patterns of collagen VI and MMP11 on adjacent sections of human breast tumors using immunohistochemistry. As expected, we observed that the adipocytes located at the invasive front abnormally expressed high levels of MMP11 (Figures 7d). Interestingly, they were no longer surrounded by the thin compact line of collagen VI (Figure 7b ) normally observed in resting adipocytes (Figure 7a) . A more or less homogenous mild or very low collagen VI staining (Figures 7b) was observed in the ECM. These Electron microscopy analysis of fat tissue from wild-type and matrix metalloproteinase 11 (MMP11)-deficient mice. Electron microscopy analysis shows that the collagen structures present at the interface between adipocytes are altered in MMP11-deficient fat tissue (c, d) compared with wild type (a, b). Moreover, in MMP11-deficient mice, disruption of adipocyte basement membrane, disruption and extensions of the plasma membrane, and lipid droplets infiltration in adjacent extracellular matrix (ECM) and cells are observed (f-h). In the wild-type mice, none of these modifications are observed (e). Magnification: bar 1 mm (a, c, e, f), 0.5 mm (b, d). Figure 7 Immunohistochemical analysis of collagen VI and matrix metalloproteinase 11 (MMP11) at the tumor invasive front of human breast cancer. Collagen VI immunohistochemistry (LB-1697 antibody) of normal breast adipose tissue (a) and invasive front of breast tumor (b). MMP11 immunohistochemistry (5ST-4A9 antibody) of normal breast adipose tissue (c) and the invasive front of breast tumor (d). Normal fat tissue located further away from the tumor is collagen VI positive and MMP11 negative. As previously described, adipocytes located at the tumor invasive front exhibit strong MMP11 expression and a considerable reduction of their sizes (Andarawewa et al., 2005) . They were no longer surrounded by the thin compact line of collagen VI observed in resting adipocytes (a). A more or less homogenous mild or very low collagen VI staining is observed in the extracellular matrix (ECM, b). (a-d) Magnification: Â 400. data indicate that MMP11 alters collagen VI at the tumor invasive front.
Discussion
An increasing number of studies highlight the importance of interactions between cancer cells and adipocytes in tumor development (Manabe et al., 2003; Celis et al., 2005; Dieudonne et al., 2006; Schaffler et al., 2007) . We have recently shown that MMP11 is involved in these processes (Andarawewa et al., 2005) . Investigations performed by Scherrer's group in the field focused on the role played by collagen VI in tumor progression (Iyengar et al., 2003; Iyengar et al., 2005) . We provide a link between these two molecules in the present study and show that MMP11 possesses collagenolytic function against the native a3 chain of collagen VI under both normal and malignant conditions.
Despite numerous studies, no matrix substrate has been identified for the MMP11. Recently, we have shown that MMP11 is a potent negative regulator of adipogenesis, able to reduce and even to revert adipocyte differentiation in an autocrine manner (Andarawewa et al., 2005) . It was therefore tempting to speculate that the MMP11 substrate might belong to adipocyte-related ECM. In this context, collagen VI is a protein highly enriched in adipocytes (Iyengar et al., 2003) . Thus, one of the important changes in the transition from fibroblast-like phenotype to adipocytes in culture models is the increase in collagen VI (Nakajima et al., 2002) . Accordingly, we observed an increase in collagen VI secreted by the mouse 3T3L1 simultaneously to their DM-induced adipocyte differentiation. If the acquirement of adipocyte phenotype induces an increase in the level of collagen VI, then we would expect that the MMP11-dependent dedifferentiation of adipocytes will be associated with a decrease of collagen VI levels. As expected, we showed that the reduction in the number and size of lipid droplets, which occurs when the adipocyte-differentiated 3T3L1 are incubated with recombinant active MMP11, correlates with the decrease in the collagen VI present in the culture medium. These data indicated that there is a relationship between MMP11 and collagen VI.
We therefore investigated the possible cleavage of collagen VI by MMP11. Collagen VI is composed of three genetically distinct a-chain subunits, a1, a2 and a3, each of which contains a relatively short triple helix, and N-and C-terminal globular regions. The a3 chain is much larger than the other two (250 versus 150 kDa). The precise protein interactions initiating and regulating formation of the unique collagen VI microfibril supramolecular assemblies are not known, but there are several steps. Following heterotrimeric assembly of the a1, a2 and a3, these monomers form higher order structures intracellularly by aligning in an antiparallel manner first to form dimers and then tetramers by lateral association of dimers. After secretion, tetramers associate end-to-end to form microfibrils (Aigner et al., 2002) . We showed that MMP11 does not cleave commercially available pepsin-solubilized collagen VI. MMP11 however cleaves the native a3 chain of collagen VI produced by the human glioblastoma cell line U87MG, but not the a1 and a2 chains. Accordingly, no MMP11 effect was observed on collagen VI produced by the osteosarcoma cell line SaOS-2, known to be devoid of a3 chain expression (Lamande et al., 2006) . The precise site of MMP11 cleavage remains to be determined. Collectively, these data clearly indicate that MMP11 possesses a collagenolytic function against the native a3 chain of collagen VI.
MMP11 belongs to the MMP family whose members share the ability to cleave one or several matrix components. Collagens constitute a very large family including more than 20 members. Among them, the main collagen types reported to be cleaved by MMP members are the types I and II (reviewed in (McCawley and Matrisian, 2001) ). At the moment, very few data are available concerning collagen VI and MMPs. It has been reported that MMP1, MMP2, MMP3 and MMP9 are unable to cleave intact collagen VI microfibrils (Kielty et al., 1993) . MMP2 however cleaves the a3 chain of the human corneal collagen VI whose disulfide bonds have been reduced (Myint et al., 1996) . Thus, collagen VI is not a common substrate for MMPs. This substrate specificity furthermore highlights the originality of MMP11 among the other MMPs (Rio, 2002) .
It has been reported that the a3 chain is essential for the formation of stable collagen VI. The C-terminal C5 domain of the a3 chain is critical for the interactions between tetramers that promote efficient microfibril formation (Lamande et al., 2006) . Thus, in articular cartilage and presumably also in other tissues a maturation process of collagen VI fibrils takes place to a significant extent in the immediate pericellular matrix compartment through proteolytic processing of the C5 domain of the a3 chain that is not present in the mature pericellular collagen VI (Aigner et al., 2002) . The nature of the proteinase involved remains unknown. From our data, we propose that MMP11 plays this role. This hypothesis is supported by the immunohistochemical analysis of fat tissue from MMP11-deficient mice, showing enlarged uncorrectly folded collagen VI surrounding adipocytes or disruption of collagen VI at the adipocyte-adipocyte interface. MMP11 is thus required in vivo for correct collagen VI folding.
It might be hypothesized that incorrectly folded and fragile collagen VI has lost, at least partially, its functionality. Accordingly, the fat tissue was less cohesive in MMP11-deficient mice than in wild-type mice. Electron microscopy ultrastructural analysis showed alteration of collagen network associated with disruption of adipocyte basement and plasma membranes. Interestingly, Kuo et al. (1997) showed that collagen VI is involved in cell adhesion by a direct interaction with collagen IV, one important component of the basement membranes. Finally, MMP11-deficient adipocytes become unable to retain lipids, allowing lipid accumulation in aberrant extracellular areas and adjacent cells. Thus, the absence of MMP11 finally leads to the alteration of the functionality of adipose tissue. As mature adipocytes are generally considered incapable or limited of division (Gregoire, 2001) , our data indicate that MMP11 is involved in fat tissue ontogenesis.
Another important function of the collagen VI has been reported in cancers. Breast cancer is associated with an increase in collagen VI expression at the level of the peritumoral adipocytes. Moreover, collagen VIdeficient mice show reduced rates of MMTV-PyMTinduced mammary tumors (Iyengar et al., 2005) . Interestingly, it has been shown that the a3 chain of collagen VI is cleaved within breast tumors. Once again, MMP11 might be expected to be involved. Indeed, under normal condition, resting adipocytes express collagen VI and are surrounded by basement membrane mainly composed of collagen VI, but they express very little MMP11. We have however previously demonstrated that invasive cancer cells induce strong MMP11 expression by adjacent adipocytes (Andarawewa et al., 2005) . Thus, invasive processes aberrantly induce simultaneous spatio-temporal overexpression and secretion of collagen VI and MMP11. In contrast to most of the other MMPs that need to be activated extracellularly, MMP11 is secreted in an enzymatically active form (Pei and Weiss, 1995) , MMP11 collagenolytic function can therefore rapidly occur at the interface between adipocytes and invasive cancer cells. Accordingly, we observed the disappearance of the thin compact collagen VI lining of adipocytes located at the invasive front of human breast cancer. Both collagen VI and MMP11 have been shown to favor tumor progression. In this context, MMP11-dependent cleavage of collagen VI might generate an increase of a C-terminal a3 chain proteolytic fragment that has been shown to possess potent growth stimulatory effects on cancer cells (Iyengar et al., 2005) . Moreover, we have previously shown that cancer cell-induced MMP11 expression by adjacent adipocytes leads to their dedifferentiation and the accumulation of peritumoral fibroblast-like cells, which are well known to promote tumor progression (Motrescu and Rio, 2008) . Collectively, the present findings suggest that the event initiating this adipocyte dedifferentiation might be the cleavage of collagen VI by MMP11.
Materials and methods
Cell lines
Mouse fibroblast 3T3L1, human glioblastoma U87MG and human osteosarcoma SaOS-2 cell lines were obtained from American Type Culture Collection (Molsheim, France). The 3T3L1 and SaOS-2 cell lines were cultured in Dulbecco's modified Eagle's medium (Gibco, Invitrogen Corporation, UK), 10% FCS and gentamicin. The U87MG cell line was cultured in minimum essential medium (Gibco, Invitrogen Corporation, UK) with 1 mM sodium pyruvate, 0.1 mM nonessential amino acids, 10% FCS and gentamicin.
Differentiation of 3T3L1 cells into adipocytes
The 3T3L1 cells were grown until they reached confluence. Subsequently, a differentiation inducing mix (DM, 10 mg/ml insulin, 0.5 mmol/l dexamethasone, 0.5 mmol/l methylisobutylxanthine) was added. After 48 h, the DM was replaced with fresh culture medium containing 10 mg/ml insulin. Cell differentiation was followed by Oil Red O staining.
Oil red O staining
The cells were fixed with 10% formalin in phosphate-buffered saline (PBS) 1 Â . After 10 min, the cells were washed three times with distilled water, air-dried and incubated at room temperature (RT) with 0.5% Oil Red O for 20 min. The cells were then washed again with distilled water and counterstained with hematoxylin as described previously (Andarawewa et al., 2005) .
Expression and purification of mouse recombinant MMP11 proteins Mouse recombinant active (F102-S276) and inactive MMP11 (same sequence with Glu220Ala mutation) were constructed in the pET3b vector. The plasmids were transformed into the expressing Escherichia coli strain BL21(DES)pLysS. The mutant proteins were obtained from insoluble protein fraction of E. coli using the previously described protocol (Kannan et al., 1999) . Briefly, after production, the bacterial cells were collected and treated to obtain bacterial inclusion bodies. Proteins were recovered, refolded and purified from inclusion bodies. Characteristics of the proteins thereby produced have been previously described (Noel et al., 1995) .
The enzymatic activity of active and inactive MMP11 was assessed using the quantitative colorimetric substrate assay with a1-PI (Kannan et al., 1999) . Briefly, the MMP11 and a1-PI incubation was left for 1 h at RT and this mixture was subsequently incubated with a-chymotrypsin for 20 min. Enzymatic activity was visualized by adding N-succinyl-AlaAla-Pro-Phe-p-nitroanilide synthetic substrate for 2 min. The optical density at 405 nm was then determined (Beckman DU640 spectrometer; Fullerton, CA, USA).
Dedifferentiation of 3T3L1 adipocytes
At day 10 after the start of differentiation, active or inactive mouse recombinant MMP11 protein was added to the culture medium for 72 h at a concentration of 3.5 mg/ml. The medium was changed every 24 h as recombinant MMP11 is susceptible to autolysis (Noel et al., 1995) .
Immunohistochemistry
Sections of human breast tumor invasive front and adjacent normal fat tissue were immunostained using the 5ST-4A9 mouse monoclonal antibody directed against MMP11 (IGBMC; Euromedex, Illkirch, France) as described previously (Basset et al., 1990) and the LB-1697 anti-collagen VI rabbit polyclonal antibody (Gentaur) directed against collagen VI extracted from placenta. LB-1697 recognizes the human and mouse a1, a2 and a3 collagen VI chains; however, the recognized epitopes remain unknown.
To perform immunohistochemistry on mouse abdominal fat tissue, adipose tissue from five wild-type and five MMP11-deficient mice was collected, embedded in paraffin and analysed using the LB-1697 polyclonal rabbit antibody for collagen VI (Gentaur).
SDS-PAGE and western blot
The cells at confluence were incubated for 24 h using medium without FCS. After 24 h of incubation, the cell culture medium was collected, centrifuged at 160 g for 5 min to remove cell debris, and kept frozen at minus 80 1C until use. Before analysis, the culture medium was thawed and subsequently 0.1% of the detergent ((3-cholamidopropyl)dimethylammo-nio)-1-propane sulfonate) was added. Afterward the culture medium was concentrated by a factor of 15 using Centricon 10 kDa separation membranes (Millipore Corporation, Bedford, MA, USA) by centrifugation at 2500 g. The protein concentration of each sample was calculated using a protein assay kit (Bio-Rad, France) and a Beckman Spectophotometer (Beckman Instruments, France). The concentrated sample was incubated with recombinant MMP11 at a ratio of 5:1 (w/w; total protein of culture medium/recombinant MMP11) for 4.5 h at 37 1C. Subsequently, the samples were prepared with SDS sample buffer and 2-mercaptoethanol, boiled for 7 min and fractionated by SDS-polyacrylamide gel electrophoresis. The gels were electrotransferred to nitrocellulose membranes (Schleicher & Schuell, Dassel, Germany) , blocked with PBS containing 3% nonfat dry milk and 0.1% Tween 20 and incubated with specific primary antibodies (collagen VI, LB-1697; endogenous MMP11, 5ST-4A9; recombinant MMP11, 5ST-4C10). Horseradish peroxidase-conjugated antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA) were used as secondary antibodies. Immunoreactive bands were visualized using an enhanced chemiluminescence detection system (Amersham Biosciences, Arlington Heights, IL, USA) and Kodak BioMax MR Film (Sigma-Aldrich, St Louis, MO, USA).
Silver nitrate staining
After the migration of the proteins on SDS-polyacrylamide gel, the gel was incubated overnight in a solution of 50% ethanol, 10% acetic acid followed by 10 min incubation with a solution of 50% ethanol, 5% acetic acid and 2% copper chloride. Afterward the gel was incubated with 0.01% potassium permanganate solution, washed with 10% ethanol solution and then with water. An incubation time period of 10 min in darkness was necessary to stain the gel using a 0.1% solution of silver nitrate. The gel was washed with water and developed in the presence of a solution of 2% potassium bicarbonate, 0.008% formaldehyde. The reaction was stopped using a 10% ethanol and 5% acetic acid solution.
Electron microscopy
For electron microscopy analysis, the tissue samples were fixed in 2.5 glutaraldehyde in cacodylate buffer overnight at 4 1C, washed for 30 min in the same buffer and then postfixed for 1 h in 1% buffered osmium tetroxide. The samples were dehydrated with gradient concentrations of ethanol and embedded in Epon 812. Ultrathin sections were cut, stained with uranyl acetate and lead citrate according to standard procedures for electron microscopy. A Morgagni 268D type microscope was used for the analysis.
